Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –2029 | |
|
|
USD 6.29 Billion |
| USD 13.05 Billion | |
| % | |
|
Global Lab- On-A-Chip Market, By Product (Instrument, Reagents and Consumables, Software and Others), Technology (Microarrays, microfluidics, Tissue Biochip and Others), Application (Genomics, Proteomics, Point of Care Diagnostics, Drug Discovery and Others), End-Use (Hospitals and Clinics, Biotechnology and Pharmaceuticals Companies, Forensic Laboratories, Diagnostics Centers and Academic and Research Institutes) – Industry Trends and Forecast to 2029
Market Analysis and Size
Lab-on-a-chip (LoC) combines many types of analysis such as chemical synthesis, biochemical activities, and DNA sequencing on a single chip. Miniaturization and optimization of these biochemical procedures have increased diagnostic speed and cost efficiency. Furthermore, LoC is a device capable of reducing single or several laboratory tasks down to chip-format, with chip sizes ranging from a few square centimeters to a few millimeters. Electronics, fluidics, optics, and biosensors are all integrated in LoC.
Data Bridge Market Research analyses that the lab-on-a-chip market which was USD 6.29 billion in 2021, would rocket up to USD 13.05 billion by 2029, and is expected to undergo a CAGR of 9.55% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Instrument, Reagents and Consumables, Software and Others), Technology (Microarrays, microfluidics, Tissue Biochip and Others), Application (Genomics, Proteomics, Point of Care Diagnostics, Drug Discovery and Others), End-Use (Hospitals and Clinics, Biotechnology and Pharmaceuticals Companies, Forensic Laboratories, Diagnostics Centers and Academic and Research Institutes)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Siemens (Germany), Abaxis (U.S), Danaher (U.S), Thermo Fisher Scientific Inc. (U.S), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S), Bio-Rad Laboratories Inc. (U.S), BD (U.S), PerkinElmer Inc. (U.S), Agilent Technologies Inc. (U.S) IDEX (U.S), Standard BioTools (U.S), Beckman Coulter Inc. (U.S), Illumina, Inc (U.S), LabSmith (U.S)
|
|
Market Opportunities
|
|
Market Definition
The lab-on-a-chip market is a miniature device that combines several laboratory analysis procedures into a single chip. Lap-on-chip technology is used for biochemical detection, DNA sequencing, and other applications. Chips can be as small as a few square centimeters in size and are capable of handling extremely small fluid quantities.
Drivers
LoC technology include excellent assay sensitivity, parallelization, ergonomics, waste minimization, and others. This technology is primarily driven by the medical profession for the identification of various diseases, which aids in sample handling, provides accurate findings in a short amount of time, and serves as a market growth driver. Furthermore, in the forecast period of 2022-2029, the rise in demand for small devices, research on biosensors and biomarkers, fabrication technology, and economic feasibility will provide new opportunities for the lab-on-a-chip market.
The integration of various disciplines and the downsizing of laboratory procedures are the hallmarks of lab-on-a-chip systems. The high level of integration required to develop LOC devices is expanding into other parts of healthcare like stem cell, drug delivery, synthetic biology, and environmental monitoring. Globally, chronic diseases are on the rise. Other factors contributing to a constant growth in frequent and costly long-term health problems include a rapidly growing global geriatric population and changes in societal behaviour. Other important factors driving the lab-on-a-chip market's growth include the use of lab-on-a-chip in the diagnosis of chronic diseases and infections.
LoC is gaining popularity in the medical area for diagnosing various infections and disorders, including HIV infections and chronic sickness, as well as botany. This is projected to propel the market forward. Because of advantages like easy portability, automated sample processing, and re-configurability, LoC devices are in great demand. Because they deliver fast and on-time diagnosis results, LoC devices are ideal for point-of-care diagnosis.
Opportunities
Due to rising investment in research and development in pharmaceuticals, life sciences, and personalised medicine, the global lab-on-a-chip market is gaining traction. In addition, various microfluidic device makers are forming partnerships or collaborations to develop more unique lab-on-a-chip applications, propelling the industry forward. Future market growth will be fuelled by technological advancements and research into LOC miniaturisation. There are many benefits of microfluidic technologies, growing demand for diagnostics, rise in R&D investments in emerging economies, and increase in global population will provide lucrative opportunities for growth for the lab-on-chip market globally.
Restraints/Challenges
The high initial purchasing cost with lack of awareness regarding lab-on-a-chip devices among the middle income countries will act as a restrain and further challenge the growth of the lab-on-a-chip market in the forecast period mentioned above.
This lab-on-a-chip market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lab-on-a-chip market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The COVID-19 pandemic had a good impact on the lab-on-a-chip market, as it has raised the focus on the creation of less time-consuming diagnostic kits, and the use of the lab-on-a-chip approach in pharmaceutical R&D has expanded. Veredus Laboratories, a Singapore-based molecular diagnostics company, recently revealed the commercial availability of a portable lab-on-a-chip diagnostic tool for detecting and distinguishing 2019-nCoV, SARS CoV, and MERS-CoV. As a result, the VereCoV detection kit combines PCR and microarray technology to give high specificity, sensitivity, and a 2-hour turnaround time. As a result, health-care facilities are time-saving diagnostic techniques.
Recent Development
The lab-on-a-chip market is segmented on the basis of product type, technology, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
Technology
Application
End-user
The lab-on-a-chip market is analysed and market size insights and trends are provided by country, product type, technology, application and end-user as referenced above.
The countries covered in the lab-on-a-chip market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America holds dominant position in the global lab-on-a-chip market.
Asia-Pacific is the fastest growing region in the global lab-on-a-chip market owing to rising population prone to viral disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The lab-on-a-chip market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to lab-on-a-chip market.
Some of the major players operating in the lab-on-a-chip market are:
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL LAB-ON-A-CHIP MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL LAB-ON-A-CHIP MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 SALES VOLUME
2.2.11 EPIDEMIOLOGY MODELLING
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL LAB-ON-A-CHIP MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 GLOBAL LAB-ON-A-CHIP MARKET, BY PRODUCT
16.1 OVERVIEW
16.2 CHIPS
16.2.1 CHIPS, BY USABILITY
16.2.1.1. DISPOSABLE
16.2.1.2. REUSABLE
16.2.2 CHIPS, BY MATERIAL
16.2.2.1. POLYMERS
16.2.2.2. GLASS
16.2.2.3. SILICON
16.2.2.4. CERAMICS
16.2.2.5. METALS
16.2.2.6. OTHERS
16.2.3 CHIPS, BY WELL PLATE
16.2.3.1. 96 WELL PLATE
16.2.3.2. 384 WELL PLATE
16.3 INSTRUMENTS
16.3.1 PCR SYSTEMS
16.3.2 ELECTROPHORESIS SYSTEMS
16.3.3 SAMPLE PREPARATION SYSTEMS
16.3.4 FLUID PROCESSOR
16.3.5 CO-CULTURE DEVICES
16.3.6 PATCH-CLAMP DEVICES
16.3.7 DIAGNOSTIC DEVICES
16.3.8 INCUBATOR
16.3.9 OTHERS
16.4 REAGENTS
16.4.1 DRY REAGENTS
16.4.1.1. PCR MASTER MIXES
16.4.1.2. PCR PRIMERS AND PROBES
16.4.1.3. CELL LYSIS REAGENTS
16.4.1.4. BEADS FOR DNA EXTRACTION
16.4.1.5. BUFFER
16.4.2 LIQUID REAGENTS
16.5 CONSUMABLES & ACCESSORIES
16.5.1 FLUIDIC INTERFACE
16.5.2 TUBING
16.5.3 SUPPORT KITS
16.5.4 HANDLING FRAMES
16.5.5 POLYMER SUBSTRATES
16.5.6 PIPETTE
16.5.7 MINI LUER
16.5.8 OTHERS
16.6 SERVICES
16.6.1 CUSTOM MODEL & ASSAY DEVELOPMENT
16.6.2 PROFILING & SCREENING
16.6.3 DRUG DEVELOPMENT
16.6.4 DEVICE DESIGN
16.6.5 COMMERCIALIZATION
16.6.6 OTHERS
16.7 SOFTWARE
16.7.1 LABCHIP GXP SECURITY SOFTWARE
16.7.2 ORACLE(R) DATABASE
16.7.3 OTHER
16.8 OTHERS
17 GLOBAL LAB-ON-A-CHIP MARKET, BY TECHNOLOGY
17.1 OVERVIEW
17.2 MICROARRAYS
17.3 MICROFLUIDICS
17.4 TISSUE BIOCHIP
17.5 OTHERS
18 GLOBAL LAB-ON-A-CHIP MARKET, BY APPLICATION
18.1 OVERVIEW
18.2 DIAGNOSTICS
18.2.1 DNA ISOLATION
18.2.2 PCR
18.2.3 QPCR
18.2.4 ELECTROPHORESIS
18.2.5 SEQUENCING
18.3 GENOMICS
18.3.1 DNA NEXT-GENERATION SEQUENCING
18.3.2 RNA NEXT-GENERATION SEQUENCING
18.4 BIOCHEMICAL ASSAYS
18.4.1 IMMUNOLOGICAL ASSAYS
18.4.2 GLUCOSE MONITORING
18.4.3 OTHERS
18.5 PROTEOMICS
18.5.1 MASS SPECTROMETRY
18.5.2 SDS-PAGE
18.6 CELL RESEARCH
18.6.1 CELL CULTURING
18.6.2 CELL MONITORING
18.6.3 OTHERS
18.7 OTHERS
19 GLOBAL LAB-ON-A-CHIP MARKET, BY END USER
19.1 OVERVIEW
19.2 HOSPITALS AND CLINICS
19.2.1 CHIPS
19.2.2 INSTRUMENTS
19.2.3 REAGENTS
19.2.4 CONSUMABLES & ACCESSORIES
19.2.5 SERVICES
19.2.6 SOFTWARE
19.2.7 OTHERS
19.3 BIOTECHNOLOGY AND PHARMACEUTICALS COMPANIES
19.3.1 CHIPS
19.3.2 INSTRUMENTS
19.3.3 REAGENTS
19.3.4 CONSUMABLES & ACCESSORIES
19.3.5 SERVICES
19.3.6 SOFTWARE
19.3.7 OTHERS
19.4 FORENSIC LABORATORIES
19.4.1 CHIPS
19.4.2 INSTRUMENTS
19.4.3 REAGENTS
19.4.4 CONSUMABLES & ACCESSORIES
19.4.5 SERVICES
19.4.6 SOFTWARE
19.4.7 OTHERS
19.5 DIAGNOSTICS CENTERS
19.5.1 CHIPS
19.5.2 INSTRUMENTS
19.5.3 REAGENTS
19.5.4 CONSUMABLES & ACCESSORIES
19.5.5 SERVICES
19.5.6 SOFTWARE
19.5.7 OTHERS
19.6 ACADEMIC AND RESEARCH INSTITUTES
19.6.1 CHIPS
19.6.2 INSTRUMENTS
19.6.3 REAGENTS
19.6.4 CONSUMABLES & ACCESSORIES
19.6.5 SERVICES
19.6.6 SOFTWARE
19.6.7 OTHERS
19.7 OTHERS
20 GLOBAL LAB-ON-A-CHIP MARKET, BY DISTRIBUTION CHANNEL
20.1 OVERVIEW
20.2 DIRECT TENDERS
20.3 RETAIL SALES
20.3.1 ONLINE SALES
20.3.2 OFFLINE SALES
20.4 OTHERS
21 GLOBAL LAB-ON-A-CHIP MARKET, BY COUNTRY
21.1 GLOBAL LAB-ON-A-CHIP MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
21.1.1 NORTH AMERICA
21.1.1.1. U.S.
21.1.1.1.1. U.S. LAB-ON-A-CHIP MARKET, BY PRODUCT
21.1.1.1.2. U.S. LAB-ON-A-CHIP MARKET, BY TECHNOLOOGY
21.1.1.1.3. U.S. LAB-ON-A-CHIP MARKET, BY APPLICATION
21.1.1.1.4. U.S. LAB-ON-A-CHIP MARKET, END USER
21.1.1.1.5. U.S. LAB-ON-A-CHIP MARKET, DISTRIBUTION CHANNEL
21.1.1.2. CANADA
21.1.1.3. MEXICO
21.1.2 EUROPE
21.1.2.1. GERMANY
21.1.2.2. FRANCE
21.1.2.3. U.K.
21.1.2.4. ITALY
21.1.2.5. SPAIN
21.1.2.6. RUSSIA
21.1.2.7. TURKEY
21.1.2.8. BELGIUM
21.1.2.9. NETHERLANDS
21.1.2.10. SWITZERLAND
21.1.2.11. REST OF EUROPE
21.1.3 ASIA-PACIFIC
21.1.3.1. JAPAN
21.1.3.2. CHINA
21.1.3.3. SOUTH KOREA
21.1.3.4. INDIA
21.1.3.5. AUSTRALIA
21.1.3.6. SINGAPORE
21.1.3.7. THAILAND
21.1.3.8. MALAYSIA
21.1.3.9. INDONESIA
21.1.3.10. PHILIPPINES
21.1.3.11. REST OF ASIA-PACIFIC
21.1.4 SOUTH AMERICA
21.1.4.1. BRAZIL
21.1.4.2. ARGENTINA
21.1.4.3. REST OF SOUTH AMERICA
21.1.5 MIDDLE EAST AND AFRICA
21.1.5.1. SOUTH AFRICA
21.1.5.2. SAUDI ARABIA
21.1.5.3. UAE
21.1.5.4. EGYPT
21.1.5.5. ISRAEL
21.1.5.6. REST OF MIDDLE EAST AND AFRICA
21.1.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
22 GLOBAL LAB-ON-A-CHIP MARKET, COMPANY LANDSCAPE
22.1 COMPANY SHARE ANALYSIS: GLOBAL
22.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
22.3 COMPANY SHARE ANALYSIS: EUROPE
22.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
22.5 MERGERS & ACQUISITIONS
22.6 NEW PRODUCT DEVELOPMENT & APPROVALS
22.7 EXPANSIONS
22.8 REGULATORY CHANGES
22.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
23 GLOBAL LAB-ON-A-CHIP MARKET, SWOT AND DBMR ANALYSIS
24 GLOBAL LAB-ON-A-CHIP MARKET, COMPANY PROFILE
24.1 ELVESYS
24.1.1 COMPANY OVERVIEW
24.1.2 REVENUE ANALYSIS
24.1.3 GEOGRAPHIC PRESENCE
24.1.4 PRODUCT PORTFOLIO
24.1.5 RECENT DEVELOPMENTS
24.2 AGILENT TECHNOLOGIES
24.2.1 COMPANY OVERVIEW
24.2.2 REVENUE ANALYSIS
24.2.3 GEOGRAPHIC PRESENCE
24.2.4 PRODUCT PORTFOLIO
24.2.5 RECENT DEVELOPMENTS
24.3 PERKIN ELMER INC.
24.3.1 COMPANY OVERVIEW
24.3.2 REVENUE ANALYSIS
24.3.3 GEOGRAPHIC PRESENCE
24.3.4 PRODUCT PORTFOLIO
24.3.5 RECENT DEVELOPMENTS
24.4 BIO-RAD LABORATRIES
24.4.1 COMPANY OVERVIEW
24.4.2 REVENUE ANALYSIS
24.4.3 GEOGRAPHIC PRESENCE
24.4.4 PRODUCT PORTFOLIO
24.4.5 RECENT DEVELOPMENTS
24.5 SEIMENS HEALTHCARE
24.5.1 COMPANY OVERVIEW
24.5.2 REVENUE ANALYSIS
24.5.3 GEOGRAPHIC PRESENCE
24.5.4 PRODUCT PORTFOLIO
24.5.5 RECENT DEVELOPMENTS
24.6 ABAXIS INC.
24.6.1 COMPANY OVERVIEW
24.6.2 REVENUE ANALYSIS
24.6.3 GEOGRAPHIC PRESENCE
24.6.4 PRODUCT PORTFOLIO
24.6.5 RECENT DEVELOPMENTS
24.7 F. HOFFMANN-LA ROCHE AGX
24.7.1 COMPANY OVERVIEW
24.7.2 REVENUE ANALYSIS
24.7.3 GEOGRAPHIC PRESENCE
24.7.4 PRODUCT PORTFOLIO
24.7.5 RECENT DEVELOPMENTS
24.8 BD
24.8.1 COMPANY OVERVIEW
24.8.2 REVENUE ANALYSIS
24.8.3 GEOGRAPHIC PRESENCE
24.8.4 PRODUCT PORTFOLIO
24.8.5 RECENT DEVELOPMENTS
24.9 ABBOTT
24.9.1 COMPANY OVERVIEW
24.9.2 REVENUE ANALYSIS
24.9.3 GEOGRAPHIC PRESENCE
24.9.4 PRODUCT PORTFOLIO
24.9.5 RECENT DEVELOPMENTS
24.1 IDEX CORPORATION
24.10.1 COMPANY OVERVIEW
24.10.2 REVENUE ANALYSIS
24.10.3 GEOGRAPHIC PRESENCE
24.10.4 PRODUCT PORTFOLIO
24.10.5 RECENT DEVELOPMENTS
24.11 DANAHER CORPORATION
24.11.1 COMPANY OVERVIEW
24.11.2 REVENUE ANALYSIS
24.11.3 GEOGRAPHIC PRESENCE
24.11.4 PRODUCT PORTFOLIO
24.11.5 RECENT DEVELOPMENTS
24.12 BIOCARE AB
24.12.1 COMPANY OVERVIEW
24.12.2 REVENUE ANALYSIS
24.12.3 GEOGRAPHIC PRESENCE
24.12.4 PRODUCT PORTFOLIO
24.12.5 RECENT DEVELOPMENTS
24.13 ENUVIO
24.13.1 COMPANY OVERVIEW
24.13.2 REVENUE ANALYSIS
24.13.3 GEOGRAPHIC PRESENCE
24.13.4 PRODUCT PORTFOLIO
24.13.5 RECENT DEVELOPMENTS
24.14 POREX
24.14.1 COMPANY OVERVIEW
24.14.2 REVENUE ANALYSIS
24.14.3 GEOGRAPHIC PRESENCE
24.14.4 PRODUCT PORTFOLIO
24.14.5 RECENT DEVELOPMENTS
24.15 DIANAX
24.15.1 COMPANY OVERVIEW
24.15.2 REVENUE ANALYSIS
24.15.3 GEOGRAPHIC PRESENCE
24.15.4 PRODUCT PORTFOLIO
24.15.5 RECENT DEVELOPMENTS
24.16 BIOMIMIX
24.16.1 COMPANY OVERVIEW
24.16.2 REVENUE ANALYSIS
24.16.3 GEOGRAPHIC PRESENCE
24.16.4 PRODUCT PORTFOLIO
24.16.5 RECENT DEVELOPMENTS
24.17 FLUID-SCREEN
24.17.1 COMPANY OVERVIEW
24.17.2 REVENUE ANALYSIS
24.17.3 GEOGRAPHIC PRESENCE
24.17.4 PRODUCT PORTFOLIO
24.17.5 RECENT DEVELOPMENTS
24.18 MICRONIT MICROFLUIDICS BV
24.18.1 COMPANY OVERVIEW
24.18.2 REVENUE ANALYSIS
24.18.3 GEOGRAPHIC PRESENCE
24.18.4 PRODUCT PORTFOLIO
24.18.5 RECENT DEVELOPMENTS
24.19 HUDSON MEDICAL INNOVATIONS
24.19.1 COMPANY OVERVIEW
24.19.2 REVENUE ANALYSIS
24.19.3 GEOGRAPHIC PRESENCE
24.19.4 PRODUCT PORTFOLIO
24.19.5 RECENT DEVELOPMENTS
24.2 Z YMERON CORPORATION
24.20.1 COMPANY OVERVIEW
24.20.2 REVENUE ANALYSIS
24.20.3 GEOGRAPHIC PRESENCE
24.20.4 PRODUCT PORTFOLIO
24.20.5 RECENT DEVELOPMENTS
24.21 THERMO FISHER SCIENTIFIC INC.
24.21.1 COMPANY OVERVIEW
24.21.2 REVENUE ANALYSIS
24.21.3 GEOGRAPHIC PRESENCE
24.21.4 PRODUCT PORTFOLIO
24.21.5 RECENT DEVELOPMENTS
24.22 MICROFLUIDIC CHIPSHOP
24.22.1 COMPANY OVERVIEW
24.22.2 REVENUE ANALYSIS
24.22.3 GEOGRAPHIC PRESENCE
24.22.4 PRODUCT PORTFOLIO
24.22.5 RECENT DEVELOPMENTS
24.23 MERCK & CO., INC.
24.23.1 COMPANY OVERVIEW
24.23.2 REVENUE ANALYSIS
24.23.3 GEOGRAPHIC PRESENCE
24.23.4 PRODUCT PORTFOLIO
24.23.5 RECENT DEVELOPMENTS
24.24 EMULATE, INC.
24.24.1 COMPANY OVERVIEW
24.24.2 REVENUE ANALYSIS
24.24.3 GEOGRAPHIC PRESENCE
24.24.4 PRODUCT PORTFOLIO
24.24.5 RECENT DEVELOPMENTS
24.25 BEONCHIP
24.25.1 COMPANY OVERVIEW
24.25.2 REVENUE ANALYSIS
24.25.3 GEOGRAPHIC PRESENCE
24.25.4 PRODUCT PORTFOLIO
24.25.5 RECENT DEVELOPMENTS
24.26 NORTIS BIO
24.26.1 COMPANY OVERVIEW
24.26.2 REVENUE ANALYSIS
24.26.3 GEOGRAPHIC PRESENCE
24.26.4 PRODUCT PORTFOLIO
24.26.5 RECENT DEVELOPMENTS
24.27 INSPHERO
24.27.1 COMPANY OVERVIEW
24.27.2 REVENUE ANALYSIS
24.27.3 GEOGRAPHIC PRESENCE
24.27.4 PRODUCT PORTFOLIO
24.27.5 RECENT DEVELOPMENTS
24.28 AXOSIM
24.28.1 COMPANY OVERVIEW
24.28.2 REVENUE ANALYSIS
24.28.3 GEOGRAPHIC PRESENCE
24.28.4 PRODUCT PORTFOLIO
24.28.5 RECENT DEVELOPMENTS
24.29 BIOIVT
24.29.1 COMPANY OVERVIEW
24.29.2 REVENUE ANALYSIS
24.29.3 GEOGRAPHIC PRESENCE
24.29.4 PRODUCT PORTFOLIO
24.29.5 RECENT DEVELOPMENTS
24.3 ALVEOLIX
24.30.1 COMPANY OVERVIEW
24.30.2 REVENUE ANALYSIS
24.30.3 GEOGRAPHIC PRESENCE
24.30.4 PRODUCT PORTFOLIO
24.30.5 RECENT DEVELOPMENTS
25 CONCLUSION
26 QUESTIONNAIRE
27 ABOUT DATA BRIDGE MARKET RESEARCH
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.